Manchester United (NYSE:MANU – Get Free Report) was upgraded by investment analysts at StockNews.com to a “sell” rating in a research note issued to investors on Tuesday.
Separately, Deutsche Bank Aktiengesellschaft dropped their price target on Manchester United from $20.30 to $16.00 and set a “hold” rating on the stock in a research note on Thursday, March 14th.
Check Out Our Latest Stock Report on MANU
Manchester United Price Performance
Institutional Investors Weigh In On Manchester United
Hedge funds and other institutional investors have recently made changes to their positions in the business. BNP Paribas Financial Markets grew its position in Manchester United by 912.0% during the first quarter. BNP Paribas Financial Markets now owns 2,277 shares of the company’s stock valued at $32,000 after acquiring an additional 2,052 shares during the period. Byrne Asset Management LLC grew its position in Manchester United by 40.1% during the fourth quarter. Byrne Asset Management LLC now owns 2,830 shares of the company’s stock valued at $58,000 after acquiring an additional 810 shares during the period. Garner Asset Management Corp purchased a new stake in Manchester United during the first quarter valued at about $153,000. Krilogy Financial LLC purchased a new stake in Manchester United during the first quarter valued at about $279,000. Finally, Aigen Investment Management LP purchased a new stake in Manchester United during the fourth quarter valued at about $344,000. Hedge funds and other institutional investors own 23.34% of the company’s stock.
About Manchester United
Manchester United plc, together with its subsidiaries, owns and operates a professional sports team in the United Kingdom. It operates Manchester United Football Club, a professional football club. The company develops marketing and sponsorship relationships with international and regional companies to leverage its brand.
See Also
- Five stocks we like better than Manchester United
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- What is Insider Trading? What You Can Learn from Insider Trading
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- Using the MarketBeat Dividend Tax Calculator
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for Manchester United Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manchester United and related companies with MarketBeat.com's FREE daily email newsletter.